+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
GKSL

Gujarat Kidney and Super Speciality Share Price

₹163.31 -8.56 (-4.98%)

30 Oct, 2026 3:50 PM (IST)

Gujarat Kidney and Super Speciality live price: ₹163.31. It opened at ₹172 vs previous close ₹172; intraday high/low: ₹173/₹161. The 50 & 200 DMA stand at ₹171.50/₹134.20.

Gujarat Kidney and Super Speciality Performance

  • Today's Low
  • ₹161
  • Today's High
  • ₹173
  • 52 Week Low
  • ₹98
  • 52 Week High
  • ₹210
  • Open Price₹172
  • Previous Close₹172
  • Volume1,011,734
  • 50 DMA₹171.50
  • 100 DMA₹157.70
  • 200 DMA₹134.20

Gujarat Kidney and Super Speciality Chart

Investment Returns

  • Over 1 Month -7.15%
  • Over 3 Month + 28.55%
  • Over 6 Month + 37.37%
  • Over 1 Year + 43.25%

Smart Investing Starts Here Start SIP with Gujarat Kidney and Super Speciality for Steady Growth!

Invest Now

Gujarat Kidney and Super Speciality Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 81.3
  • PEG Ratio
  • -
  • Market Cap Cr
  • 1,288
  • P/B Ratio
  • 5
  • Average True Range
  • 8.4
  • EPS
  • 2
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.2
  • RSI
  • 35.73
  • MFI
  • 31.93

Latest Stock News Updates

Gujarat Kidney and Super Speciality Ltd - 544666 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Earning Con-call

Gujarat Kidney and Super Speciality Ltd - 544666 - Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results For The Quarter Ended September 30, 2026.

Gujarat Kidney And Super Speciality Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended September 30, 2026. 2. To discuss any other matters with the permission of the Chairman.

Gujarat Kidney and Super Speciality Ltd - 544666 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg 74 (5) of SEBI (DP) Regulations

Gujarat Kidney and Super Speciality Financials

Gujarat Kidney and Super Speciality Technicals

EMA & SMA

Current Price
₹163.31
-8.56 (-4.98%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹177.90
  • 50 Day
  • ₹171.50
  • 100 Day
  • ₹157.70
  • 200 Day
  • ₹134.20

Resistance and Support

165.57 Pivot Speed
  • R3 182.10
  • R2 177.30
  • R1 170.30
  • S1 158.60
  • S2 153.80
  • S3 146.80

Gujarat Kidney and Super Speciality Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-04 Quarterly Results
2026-08-14 Quarterly Results
2026-05-28 Audited Results
2026-02-14 Quarterly Results (Revised)

Gujarat Kidney and Super Speciality Shareholding Pattern

71.45%
21.77%
6.52%
0.25%

About Gujarat Kidney and Super Speciality

Gujarat Kidney & Super Speciality samulti specialty health care institution and is engaged in providing comprehensive medical services, including inpatient and out patientcare, surgical procedures, diagn sticservices, and emergency care. View More
  • NSE Symbol
  • GKSL
  • BSE Symbol
  • 544666
  • ISIN
  • INE0V0W01025

Similar Stocks to Gujarat Kidney and Super Speciality

Gujarat Kidney and Super Speciality FAQs

Gujarat Kidney and Super Speciality share price is ₹163 As on 01 November, 2026 | 03:20

The Market Cap of Gujarat Kidney and Super Speciality is ₹1287.6 Cr As on 01 November, 2026 | 03:20

The P/E ratio of Gujarat Kidney and Super Speciality is 81.3 As on 01 November, 2026 | 03:20

The PB ratio of Gujarat Kidney and Super Speciality is 5 As on 01 November, 2026 | 03:20

The 52 week High & Low of Gujarat Kidney and Super Speciality is ₹209.8/₹98.4 respectively As on 01 November, 2026 | 03:20

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23